Quantitative determination of antibodies to SARS-CoV-2 is becoming increasingly important as it provides a good assessment of the actual spread of COVID-19 infections. It plays an important role in characterizing a vaccine-induced immune response and allows quantification of antibody levels in plasmapheresis donations used to treat COVID-19 patients with a severe course.
SARS-CoV-2 UTAB FS is an immunoturbidimetric test to determine total antibodies in human serum. The test is characterized by high specificity and sensitivity and shows no cross-reactivity with antibodies present to other seasonal cold pathogens from the corona virus group (OC43, 229E, NL63, HKU1).
The test provides comparable results on almost all clinical chemistry analyzers. It enables reliable monitoring of patients, which is currently a major challenge, especially in the context of testing the efficacy of new vaccines, as available antibody tests have different reaction principles and can usually only be used on the manufacturers’ platforms.
The liquid stable, ready-to-use reagent with matched calibrators, controls and sample dilution matrix is available now.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.